Reply to Letter to the Editor on Mease et al.

Publication Title

Arthritis Rheumatol

Authors

Philip Mease, Swedish Medical Center/Providence St. Joseph Health and the University of Washington, Seattle, Washington, USAFollow
David H Collier
Gregory Kricorian
James B Chung

Document Type

Article

Publication Date

4-7-2020

Abstract

We read with interest the Letter to the Editor by Kerschbaumer et al regarding our article on the primary results from the SEAM-PsA trial (1). We appreciated the comments highlighting the methotrexate (MTX) monotherapy results. Since MTX is a drug that has been long used in psoriatic arthritis (PsA) without much data from rigorous and well-controlled clinical trials, we sought to provide reliable data about MTX through SEAM-PsA.

Clinical Institute

Orthopedics & Sports Medicine

Specialty/Research Institute

Rheumatology